Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2010Molecular Pharmaceutics

MEK Inhibition Potentiates the Activity of Hsp90 Inhibitor 17-AAG against Pancreatic Cancer Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

TZTao ZhangChinese University of Hong KongYLYanyan LiCentral South UniversityZZZhenkun Zhu

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2010) studied this question.

synapsesocial.com/papers/6a2022d3f8c30f43cdfbee56https://doi.org/10.1021/mp900321a
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1ERK and Beyond: Insights from B-Raf and Raf-1 Conditional Knockouts2006 · 90 citations
  2. 2Recent Advances in Hsp90 Inhibitors as Antitumor Agents2008 · 102 citations
  3. 3Progress Towards Therapeutic Small Molecule MEK Inhibitors for Use in Cancer Therapy2005 · 70 citations
  4. 4Cooperative inhibitory effect of ZD1839 (Iressa) in combination with 17‐AAG on glioma cell growth2006 · 33 citations
  5. 5Regulation of Cell Motility by Mitogen-activated Protein Kinase1997 · 1,249 citations